Abstract
We experienced a case of fulminant myocarditis complicated by severe lung ischemia–reperfusion injury after switching from veno-arterial extracorporeal membrane oxygenation to biventricular assist device. We controlled lung blood flow by hybrid veno-arterial extracorporeal membrane oxygenation, which was established by modifying the biventricular assist device circuit without resternotomy, blood delivery to the pulmonary artery and blood removal from the left ventricle in addition to central veno-arterial extracorporeal membrane oxygenation, and accelerated lung recovery. The patient’s lung damage and cardiac function were restored, and she completely recovered and was discharged without any complications. Regulation of lung blood flow is important and effective for lung ischemia–reperfusion injury after biventricular assist device implantation.
Similar content being viewed by others
References
Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and initial management of fulminant myocarditis. A Scientific statement from American Heart Association. Circulation. 2020;141:69–92.
van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136:e232–68.
Saito S, Toda K, Miyagawa S, Yoshioka Y, Hata H, Yoshioka D, Domae K, Tsukamoto Y, Sakata Y, Sawa Y. Diagnosis, medical treatment, and stepwise mechanical circulatory support for fulminant myocarditis. J Artif Organs. 2018;21:172–9.
Laubach VE, Sharma AK. Mechanism of lung ischemia-reperfusion injury. Curr Opin Organ Transplant. 2016;21:246–52.
Weyker PD, Webb CA, Kiamanesh D, Flynn BC. Lung ischemia reperfusion injury: a bench-to-bedside review. Semin Cardiothorac Vasc Anesth. 2013;17:28–43.
den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL. Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010;299:H1283–99.
Author information
Authors and Affiliations
Contributions
All authors have read the manuscript and have agreed with submission. Contributions of our authors are following: AM: patient’s care, collection and analysis of data, manuscript writing. TN: patient’s care. MI: patient’s care. TM: patient’s care. MK: patient’s care. SK: supervision.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mano, A., Nishimura, T., Ishii, M. et al. Usefulness of hybrid veno-arterial extracorporeal membrane oxygenation for lung ischemia–reperfusion injury after biventricular assist device implantation. J Artif Organs 25, 266–269 (2022). https://doi.org/10.1007/s10047-022-01310-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-022-01310-x